Articles By Gregory McDermott, MD

CT scan

SARD-ILD: Significant diagnostic and treatment delays

By Gregory McDermott, MD

Should we be screening all our patients with systemic autoimmune rheumatic disease (SARD) for interstitial lung disease? I have been asking myself that question after the recent publication of American Thoracic Society Interstitial Lung Disease screening guidelines. The ATS guidelines, which were published in May, recommend universal CT chest screening for all asymptomatic patients with RA, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren’s disease.

Read Article
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

Profile picture for user Gregory McDermott, MD
  • Gregory McDermott, MD

  • Gregory McDermott is an Instructor of Medicine at Harvard Medical School and Attending Rheumatologist at Brigham and Women’s Hospital. His research interests include risk factors for rheumatoid arthritis-associated lung diseases and the use of genetics and other biomarkers to predict treatment response and disease outcomes in rheumatology.

×